Pfizer's Hospira plant in McPherson, Kansas has repeatedly breached the US Food and Drug Administration's good practice standards since 2012. Posted 07 December 2018 | Photograph: Violations dating from 2012 include failing to stop supposedly sterile drugs from being contaminated and laxity in reporting instances of not meeting established specifications with batches of a drug. Other violations include persistent manufacturing issues in processing areas and inadequate training of staff.
Pfizer's Hospira plant in McPherson, Kansas has repeatedly breached the US Food and Drug Administration's good practice standards since 2012. Photograph: Violations dating from 2012 include failing to stop supposedly sterile drugs from being contaminated and laxity in reporting instances of not meeting established specifications with batches of a drug. Other violations include persistent manufacturing issues in processing areas and inadequate training of staff.